Table III.

Associations between the expression of MORC2 and the clinicopathologic features of liver cancer (GSE14520).

Characteristic	Patients (n)	Expression ofmicrorchidia 2		P-value
		High	Low
Age (years)
≤55	166	88	77	0.166
>55	76	33	43
Sex
Male	211	108	103	0.336
Female	31	13	18
AFP (ng/ml)
≤200	128	58	70	0.119
>200	110	61	49
ALT (U/l)
≤50	142	64	78	0.068
>50	100	57	43
Cirrhosis
Yes	223	112	111	0.811
No	19	9	10
Tumor size (d/cm)
<5	153	67	86	0.009
≥5	88	54	34
Tumor number
Solitary	190	91	99	0.211
Multiple	52	30	22
AJCC T stage
T1	96	34	62	0.007
T2	78	43	35
T3	51	30	21
BCLC stage
0	20	8	12	0.283
A	152	68	84
B	24	13	11
C	29	18	11
CLIP stage
0	98	41	57	0.297
1	79	40	39
2,3,4,5	48	26	22
PRMS classification
High	121	74	47	<0.001
Low	121	47	74

Data are presented as numbers. AJCC, American Joint Committee on Cancer; BCLC, Barcelona Clinic Liver Cancer; CLIP, Cancer Liver Italian Program; PRMS, Predicted risk Metastasis Signature.